Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    23526949 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant
Condition: Malaria
Interventions: Biological: R21/Matrix-M1;   Other: Saline
2 Completed Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination
Condition: Ebola Virus Disease
Interventions: Biological: ChAd3-EBO Z;   Biological: MVA-EBO Z
3 Completed Safety and Immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP Vaccines in Malaria Endemic Areas
Condition: Malaria
Intervention: Biological: AdCh63 ME-TRAP followed by MVA ME-TRAP
4 Completed AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Adults and Children in a Malaria Endemic Area
Condition: Malaria
Interventions: Biological: AdCh63 ME-TRAP, MVA ME-TRAP;   Biological: HDCRV

Indicates status has not been verified in more than two years